Humber College – Injection Training Certificate Program for Pharmacy Technicians

Master core immunization practices and learn how to adequately administer vaccines by injection.

  • Visit the “In-person live session” section below for available dates/locations. You may choose your live session after registration.
  • The course is accessed by the same account that makes the purchase. Owners/Managers registering their staff should have them register under their own account.




This program is tailored for pharmacy technicians and is recognized by the Ontario College of Pharmacists (OCP) for registered pharmacy technician injection training. The program also addresses the 7 competencies approved and required by The Canadian Council on Continuing Education in Pharmacy (CCCEP).

In-person live session:

This mandatory in-person live session is for the practical exam portion of the course. Your course instructor will give you the information regarding time and location of the assessment.

Course outline:

Online Component (4 hours):

  • Online learning modules
  • Final multiple-choice exam
  • Reflective exercise
  • Program evaluation

In-Person Live Session:

  • Practicing techniques
  • Practical exam (demonstration of intramuscular and subcutaneous injections on a partner)

Course at a glance:

  • 5 CEUs
  • Available until January 24, 2024
  • Blended (Online & In-Person)
  • Accreditation: 8003-2021-3151-B-T
  • Completion requirement: Complete the program’s online component. Attend the in-person live session and successfully demonstrate the skills required to administer subcutaneous and intramuscular injections. Achieve 70% or more on the final multiple- choice exam (maximum two attempts) and complete the reflective exercise and evaluations before the course expiry date.

Who should take this course:

The Injections Training Certificate Program for Pharmacy Technicians is a two-part series designed to support pharmacy technicians in the provision of injections for COVID-19 and influenza vaccines (under specific conditions).

Development Team:

  • Sherilyn Houle, PhD - Assistant Professor, University of Waterloo
  • Leah O’Neal, RPhT
  • Mova Leung, RPh (PharmD)
  • Tiana Tilli, RPh, ACPR (PharmD)